Measles Cases in the United States by Year: Key Trends and Public Health Context
Measles cases in the United States by year reflect the impact of vaccination, outbreak cycles, and population immunity rather than a single steady pattern. Before widespread vaccination, annual cases numbered in the hundreds of thousands, with sharp epidemics every few years. Following introduction of the measles vaccine in the 1960s and the two-dose MMR schedule in the 1990s, case counts dropped dramatically. Most years from the 1990s through the early 2010s saw fewer than 100–200 cases annually. When cases do rise, they are often linked to importation, under-vaccinated communities, and opportunities for local spread. This overview explains the data sources, definitions, and long-term patterns to help you understand annual trends and their public health meaning.
Measles Reporting in the United States: Methods and Definitions
Notifiable Disease Status and Data Sources
Measles is a nationally notifiable disease, meaning clinicians and laboratories must report each probable and confirmed case to state and local health departments. These agencies report to the Centers for Disease Control and Prevention (CDC) through the National Notifiable Diseases Surveillance System (NNDSS). Additional context comes from the National Immunization Survey (NIS), vaccination coverage reports, and outbreak investigations. Because measles is rare in most U.S. populations, public health systems emphasize rapid detection and response to importation events.
Case Definitions and Laboratory Criteria
The CDC uses standardized case definitions that distinguish confirmed, probable, and suspect cases. A confirmed case typically requires laboratory evidence, such as a positive PCR test, seroconversion, or detection of measles IgM in a suitable specimen. Probable cases may meet clinical criteria with compatible epidemiologic linkage, while suspect cases are reported clinically but lack laboratory confirmation. Consistent definitions across years allow for more reliable comparisons, though changes in testing practices and reporting can still influence counts year to year.
Historical Measles Cases by Year in the United States
Examining annual reported measles cases in the United States illustrates how vaccination, public health response, and community immunity shape disease patterns. The table below focuses on select periods and milestones most relevant to interpreting year-to-year variation.
| Period or Year | Reported Cases (Approximate Range) | Verified Detail or Context | Source Type |
|---|---|---|---|
| 1950s (pre-vaccine) | 3–4 million annually | High endemicity with frequent epidemics | CDC historical summaries |
| 1963 (first vaccine introduced) | 498,000 | Early decline begins after licensure | CDC Morbidity and Mortality Weekly Report (MMWR) |
| 1967–1978 | 50,000–200,000 per year | Attenuated vaccine strains refined; coverage increases | CDC historical data |
| 1978–1981 | 15,000–40,000 per year | Catch-up campaigns and improved routine coverage | CDC MMWR |
| 1990–1991 | 2,326–5,894 | Two-dose school-entry policies implemented | CDC MMWR |
| 1993–1994 | 388–811 | Low endemicity maintained through high coverage | CDC data |
| 2000 (intermediate milestone) | 86 | Measles declared eliminated; endemic transmission interrupted | CDC, Advisory Committee on Immunization Practices (ACIP) |
| 2008 | 131 | First year with measles fatalities since 1993; importation-driven outbreaks | CDC MMWR |
| 2014 | 667 | Large multistate outbreak linked to an amusement venue; highest since 2000 | CDC MMWR |
| 2019 | 1,282 | Multiple large outbreaks in under-vaccinated communities; highest since 1992 | CDC MMWR |
| 2020–2023 | 59–1,512 (annual range) | COVID-19 impacts on healthcare use and vaccination coverage; lower 2020–2021, rebound in 2023 | CDC, state health department data |
Interpretation of Year-to-Year Changes
Reported measles cases by year are influenced by multiple factors beyond true changes in transmission intensity. These include vaccination coverage levels, the occurrence of importations from other countries, the size and density of under-vaccinated communities, and public health detection and reporting practices. Outbreaks often start with a single imported case that spreads among unvaccinated or undervaccinated individuals. Even in years with relatively low totals, sporadic cases and small clusters can occur, highlighting the importance of maintaining high MMR coverage to prevent larger epidemics.
Vaccination as the Primary Driver of Trends
Impact of the Measles Vaccine
The introduction of measles vaccine in 1963 produced an immediate and sharp decline in annual cases. The shift to a two-dose MMR vaccine schedule in the 1990s further improved population immunity and reduced endemic transmission. High routine coverage produces indirect protection by reducing opportunities for virus circulation, an effect known as herd immunity. When coverage drops locally, clusters become vulnerable to outbreaks even in populations with otherwise high overall immunization.
Recent Patterns and Outbreak Drivers
In recent years, increases in U.S. measles cases have most often been tied to importation and sustained transmission in under-vaccinated communities. Factors associated with lower coverage include delayed vaccination, parental nonmedical exemptions, and difficulty reaching mobile or marginalized populations. Public health responses typically involve rapid case identification, contact tracing, postexposure vaccination, and community outreach to restore high coverage and interrupt transmission.
Current Status and What Future Years May Hold
As of the most recent full year available, the United States continues to record measles cases, though at relatively low levels compared with historical peaks. Annual numbers remain far below pre-vaccine epidemics but can rise sharply when outbreaks occur. Ongoing risks include continued international importation, pockets of undervaccinated individuals, and waning public attention to vaccination. Sustained high MMR coverage is the most reliable way to keep annual case counts low and prevent large epidemics.
Data Limitations and Considerations
Reported case counts can vary due to changes in laboratory testing, case definitions, and reporting completeness. Not all clinically compatible cases are virologly confirmed, and some years may see higher detection because of increased outbreak investigation activity. Comparisons across years should therefore focus on broad patterns rather than exact year-to-year differences. Understanding these limitations helps avoid overinterpretation of any single annual total.
- Measles is rare in the United States but remains a global health threat, with millions of cases and hundreds of thousands of deaths worldwide each year.
- High MMR coverage not only protects individuals but also limits opportunities for measles to circulate and spread.
- Imported cases often originate from regions where measles is still common and can seed outbreaks in under-vaccinated communities.
- Public health systems rely on timely reporting, rapid laboratory confirmation, and coordinated outbreak control to keep case numbers low.
Conclusion: Why Yearly Trends Matter
Measles cases by year in the United States reveal the outsized effect of vaccination, the risk of importation, and the importance of resilient public health systems. Historically high epidemics gave way to low endemicity through vaccine introduction and improved coverage, but recent outbreaks show that gains can be reversed where immunity is incomplete. Continued vigilance, accurate data, and evidence-based communication remain essential to sustaining elimination and protecting communities against measles over the long term.